Temperature-Regulating Therapy for Insomnia in Tourette Syndrome
Trial Summary
What is the purpose of this trial?
This trial tests a forehead temperature-regulating device to help adults with Tourette's disorder sleep better. The device adjusts forehead temperature to improve brain function and sleep quality.
Will I have to stop taking my current medications?
The trial requires that you do not change your prescribed or over-the-counter medications for sleep or tics within the month before and during the study.
What data supports the effectiveness of the treatment Forehead Temperature-Regulating Therapy, Frontal Cerebral Thermal Therapy for insomnia in Tourette Syndrome?
Research suggests that people with Tourette syndrome may have issues with body temperature regulation, possibly due to a hypothalamic disorder (a problem with a part of the brain that controls body temperature). This implies that treatments targeting temperature regulation might help manage symptoms, including sleep disturbances.12345
How is Forehead Temperature-Regulating Therapy different from other treatments for insomnia in Tourette Syndrome?
Forehead Temperature-Regulating Therapy is unique because it targets the regulation of body temperature, which may be disrupted in Tourette Syndrome due to possible hypothalamic dysfunction. This approach is different from traditional treatments that focus on managing tics and other symptoms with medications or behavioral therapies.12345
Research Team
Emily J Ricketts, PhD
Principal Investigator
University of California, Los Angeles
Eligibility Criteria
Adults aged 18-50 with Tourette's disorder and insomnia, who have a Yale Global Tic Severity Scale Score of at least 14 (or ≥10 for other tic disorders), sleep efficiency ≤85% on half or more nights, and an Insomnia Severity Index score >14. Excluded are those with bipolar disorder, psychosis, severe depression/anxiety within the last 6 months, high risk of sleep apnea, narcolepsy, irregular sleep schedules, Raynaud's disease or severe cold sensitivity.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-treatment Evaluation
Participants complete assessments for tic severity, depression, anxiety, and daytime sleepiness, and monitor sleep for seven nights using a wrist actigraph and sleep diary
Treatment
Participants use a forehead temperature-regulating therapy device nightly for four weeks, with continuous sleep monitoring using actigraph and sleep diary
Post-treatment Assessment
Participants complete a post-treatment assessment involving clinician-rated tic severity interview and re-rating of depression, anxiety, and daytime sleepiness measures
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Forehead Temperature-Regulating Therapy (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
Dr. Thomas Rando
University of California, Los Angeles
Chief Medical Officer since 2023
MD from UCLA
Amir Naiberg
University of California, Los Angeles
Chief Executive Officer since 2024
JD from UCLA
Brain & Behavior Research Foundation
Collaborator
Dr. Jeffrey Borenstein
Brain & Behavior Research Foundation
Chief Executive Officer since 2018
MD from New York University, undergraduate degree from Harvard
Dr. Herbert Pardes
Brain & Behavior Research Foundation
Chief Medical Officer since 2017
MD from Harvard Medical School